We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AKVANO

News List

Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis prnasia
April 23, 2021
Lipidor AB (publ) provides an update on the planned Phase III study of the company's drug candidate AKP02 for the treatment of psoriasis. During the first quarter of 2021, Lipidor submitted an application to the Indian Medical Products Agency for ...
Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology prnasia
October 09, 2020
Lipidor AB today announces a positive outcome of the feasibility study into the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions.